BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Gaotu Techedu
GOTU
$458M
| $69.7M | ﹤0.01% |
4,716,309
+1,364,328
| +41% | +$30.4M |
|
2477
Kearny Financial
KRNY
$610M
| $69.3M | ﹤0.01% |
5,802,572
-584,542
| -9% | -$7.39M |
|
2478
UiPath
PATH
$7.31B
| $69.3M | ﹤0.01% |
+1,019,428
| New | +$74.8M |
|
2479
Groupon
GRPN
$1.04B
| $69M | ﹤0.01% |
1,597,894
-160,614
| -9% | -$7.56M |
|
|
2480
CALL
Microsoft
MSFT
$3.66T
| $68.9M | ﹤0.01% |
254,400
-299,700
| -54% | -$76.2M |
|
2481
Titan International
TWI
$466M
| $68.8M | ﹤0.01% |
8,108,922
+2,399,121
| +42% | +$23.4M |
|
|
XRN
2482
Chiron Real Estate Inc
XRN
$467M
| $68.7M | ﹤0.01% |
931,092
+151,953
| +20% | +$11M |
|
2483
ALX Oncology
ALXO
$260M
| $68.5M | ﹤0.01% |
1,252,305
-266,175
| -18% | -$15.9M |
|
2484
Weis Markets
WMK
$1.94B
| $68.4M | ﹤0.01% |
1,323,128
+47,859
| +4% | +$2.54M |
|
2485
OptimizeRx
OPRX
$123M
| $68.3M | ﹤0.01% |
1,104,157
+25,268
| +2% | +$1.29M |
|
|
CAMP
2486
DELISTED
CalAmp Corp.
CAMP
| $68.3M | ﹤0.01% |
233,596
-9,572
| -4% | -$2.85M |
|
2487
Petco
WOOF
$831M
| $68.3M | ﹤0.01% |
3,047,544
+313,463
| +11% | +$7.33M |
|
|
TSC
2488
DELISTED
TriState Capital Holdings, Inc.
TSC
| $68.2M | ﹤0.01% |
3,344,223
-15,080
| -0.4% | -$344K |
|
|
DMTK
2489
DELISTED
DermTech, Inc. Common Stock
DMTK
| $68.2M | ﹤0.01% |
1,640,072
+677,518
| +70% | +$27.8M |
|
2490
Quince Therapeutics
QNCX
$24.4M
| $68.1M | ﹤0.01% |
6,423
-390
| -6% | -$3.27M |
|
|
BMTC
2491
DELISTED
Bryn Mawr Bank Corp
BMTC
| $68M | ﹤0.01% |
1,612,931
-185,738
| -10% | -$8.51M |
|
|
CERE
2492
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $68M | ﹤0.01% |
2,652,558
+1,554,987
| +142% | +$22.3M |
|
2493
Reynolds Consumer Products
REYN
$5.32B
| $67.8M | ﹤0.01% |
2,235,092
+85,296
| +4% | +$2.59M |
|
2494
Omeros
OMER
$909M
| $67.8M | ﹤0.01% |
4,566,247
-494,208
| -10% | -$8.29M |
|
|
KRON
2495
DELISTED
Kronos Bio
KRON
| $67.6M | ﹤0.01% |
2,822,245
+1,186,681
| +73% | +$30M |
|
2496
Sutro Biopharma
STRO
$416M
| $67.4M | ﹤0.01% |
362,680
+52,483
| +17% | +$10.3M |
|
|
FFWM
2497
DELISTED
First Foundation Inc
FFWM
| $67.3M | ﹤0.01% |
2,991,811
-234,561
| -7% | -$5.63M |
|
2498
Motorcar Parts of America
MPAA
$257M
| $67.3M | ﹤0.01% |
2,998,322
-50,009
| -2% | -$1.14M |
|
|
AEPPL
2499
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
| $67.2M | ﹤0.01% |
1,368,390
+42,133
| +3% | +$2.09M |
|
2500
iShares Global Consumer Discretionary ETF
RXI
$275M
| $67M | ﹤0.01% |
390,877
-220,955
| -36% | -$37.2M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.